Results of a phase I trial evaluating a liver support device utilizing albumin dialysis

Surgery

Volumn 130, Issue 2, 2001, Pages 354-362

  Awad, Samir S ^a,b   Swaniker, Fresca ^a,b   Magee, John ^a,b   Punch, Jeffrey ^a,b   Bartlett, Robert H ^a,b  

^a UNIVERSITY OF MICHIGAN HOSPITALS   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; AMMONIA; BILIRUBIN; BLOOD CLOTTING FACTOR 7; TOXIN;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEVICE; DIALYSIS; EXTRACORPOREAL CIRCULATION; HEART RATE; HEMODIALYSIS; HEMODYNAMICS; HEPATIC ENCEPHALOPATHY; HUMAN; INTRACRANIAL PRESSURE; LIVER FAILURE; LIVER FUNCTION; LIVER TRANSPLANTATION; MEAN ARTERIAL PRESSURE; PRIORITY JOURNAL; PROTEIN BINDING; VENOUS OXYGEN TENSION;

EID: 0034896528     PISSN: 00396060     EISSN: None     Source Type: Journal    
DOI: 10.1067/msy.2001.116671     Document Type: Article

References (25)

1. Acute liver failure
2. Hepatology: A century of progress - Fulminant hepatic failure
3. Current stares of liver support systems
4. Tissue hypoxia during fulminant hepatic failure
5. Extracorporeal perfusion for the treatment of acute liver failure
6. Treatment of hepatic failure with ex-vivo pig liver perfusion followed by transplantation
7. A polyacrylonitrile membrane interposition between a xenograft and a patient in fulminant liver failure: The concept of xenohemodiafiltration in clinical practice
8. Clinical experience with a bioartificial liver in the treatment of severe liver failure
9. The Hepatix extracorporeal liver assist device: Initial clinical experience
10. Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure
11. Treatment of encephalopathy during fulminant hepatic failure by haemodialysis with high permeability membrane
12. Postdilution hemofiltration in the management of acute hepatic failure: A pilot study
13. Plasma exchange in patients with fulminant hepatic failure
14. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure
15. Evaluation of the biological-DT sorbent-suspension dialyser in patients with fulminant hepatic failure
16. In vitro and clinical studies of the removal of cortisol, thyroxine, insulin, and thyroid-stimulating hormone by coated charcoal haemoperfusion
17. Complement activation as a cause of transient hypotension during plasmapheresis
18. A new procedure for the removal of protein bound drugs and toxins
19. Molecular Adsorbent Recycling System (MARS) - A new membrane based blood purification system for bioartificial liver support - Clinical results
20. Characteristics of an albumin dialysate hemodiafiltration system for the clearance of unconjugated bilirubin
21. Can the clearance of phenylalanine be enhanced using an albumin dialysate hemodiafiltration system?
22. Can the clearance of TNF-alpha and interleukin 6 be enhanced using an albumin dialysate hemodiafiltration system?
23. Evaluation of a non-cell based extracorporeal liver support device in an animal model of hepatic failure
24. Developing indications for extracorporeal liver support (ECLVS)
25. The Molecular Adsorbents Recycling System (MARS) as a liver support system based on albumin dialysis - A summary of preclinical investigations, prospective randomized controlled clinical trial, and clinical experience from 19 centers